OBJECTIVE: To compare outcomes and survival times for dogs with cervical spondylomyelopathy (CSM; wobbler syndrome) treated medically or surgically. DESIGN: Retrospective case series. ANIMALS: 104 dogs. PROCEDURES: Medical records of dogs were included if the diagnosis of CSM had been made on the basis of results of diagnostic imaging and follow-up information (minimum, 6 months) was available. Ordinal logistic regression was used to compare outcomes and the product-limit method was used to compare survival times between dogs treated surgically and dogs treated medically. RESULTS: 37 dogs were treated surgically, and 67 were treated medically. Owners reported that 30 (81%) dogs treated surgically were improved, 1 (3%) was unchanged, and 6 (16%) were worse and that 36 (54%) dogs treated medically were improved, 18 (27%) were unchanged, and 13 (19%) were worse. Outcome was not significantly different between groups. Information on survival time was available for 33 dogs treated surgically and 43 dogs treated medically. Forty of the 76 (53%) dogs were euthanized because of CSM. Median and mean survival times were 36 and 48 months, respectively, for dogs treated medically and 36 and 46.5 months, respectively, for dogs treated surgically. Survival times did not differ significantly between groups. CONCLUSIONS AND CLINICAL RELEVANCE: In the present study, neither outcome nor survival time was significantly different between dogs with CSM treated medically and dogs treated surgically, suggesting that medical treatment is a viable and valuable option for management of dogs with CSM.
OBJECTIVE: To compare outcomes and survival times for dogs with cervical spondylomyelopathy (CSM; wobbler syndrome) treated medically or surgically. DESIGN: Retrospective case series. ANIMALS: 104 dogs. PROCEDURES: Medical records of dogs were included if the diagnosis of CSM had been made on the basis of results of diagnostic imaging and follow-up information (minimum, 6 months) was available. Ordinal logistic regression was used to compare outcomes and the product-limit method was used to compare survival times between dogs treated surgically and dogs treated medically. RESULTS: 37 dogs were treated surgically, and 67 were treated medically. Owners reported that 30 (81%) dogs treated surgically were improved, 1 (3%) was unchanged, and 6 (16%) were worse and that 36 (54%) dogs treated medically were improved, 18 (27%) were unchanged, and 13 (19%) were worse. Outcome was not significantly different between groups. Information on survival time was available for 33 dogs treated surgically and 43 dogs treated medically. Forty of the 76 (53%) dogs were euthanized because of CSM. Median and mean survival times were 36 and 48 months, respectively, for dogs treated medically and 36 and 46.5 months, respectively, for dogs treated surgically. Survival times did not differ significantly between groups. CONCLUSIONS AND CLINICAL RELEVANCE: In the present study, neither outcome nor survival time was significantly different between dogs with CSM treated medically and dogs treated surgically, suggesting that medical treatment is a viable and valuable option for management of dogs with CSM.
Authors: Paula Martin-Vaquero; Ronaldo C da Costa; Matthew J Allen; Sarah A Moore; Jeremy K Keirsey; Kari B Green Journal: Spine (Phila Pa 1976) Date: 2015-05-01 Impact factor: 3.468
Authors: Domenico Fugazzotto; Chiara Costa Devoti; Ilaria Anna Cassano; Chiara Teani; Elisa Berti; Marta Brusati; Offer Zeira Journal: Rev Bras Med Vet Date: 2022-04-12
Authors: Kendy Tzu-Yun Teng; Brecht Devleesschauwer; Charline Maertens De Noordhout; Peter Bennett; Paul D McGreevy; Po-Yu Chiu; Jenny-Ann L M L Toribio; Navneet K Dhand Journal: PLoS One Date: 2018-09-12 Impact factor: 3.240
Authors: Tjarda E Reints Bok; Koen Willemsen; Mattie H P van Rijen; Guy C M Grinwis; Marianna A Tryfonidou; Björn P Meij Journal: Vet Surg Date: 2019-08-22 Impact factor: 1.495
Authors: Daniella P Vansteenkiste; Joelle M Fenger; Paolo Fadda; Paula Martin-Vaquero; Ronaldo C da Costa Journal: J Vet Intern Med Date: 2019-10-22 Impact factor: 3.333
Authors: Steven De Decker; Ingrid M V L Gielen; Luc Duchateau; Holger A Volk; Luc M L Van Ham Journal: BMC Vet Res Date: 2012-07-28 Impact factor: 2.741
Authors: Carolyn Nye; Eric Hostnik; Elizabeth Parker; Thomas Wittum; Stephen Jones; Sarah Moore; Laurie Cook; Ronaldo C da Costa Journal: J Vet Intern Med Date: 2020-08-14 Impact factor: 3.333